Uncategorized
Making custom CRISPR therapies could be harder than initially thought
Last year’s successful treatment of an infant known as Baby KJ encouraged scientists to try again. But now, five weeks after the FDA outlined its plans to make such individualized genetic medicines more accessible, researchers …